Xilio Therapeutics financial statements

자일리오 테라퓨틱스NASDAQ:XLO · Nasdaq · Healthcare · sector #13
$9.11+1.11%
2026-10-05 close

Xilio Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $6M. 2024 operating profit was −$61M.

Reported results

Xilio Therapeutics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q